Drug intelligence / Profile preview

6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL

Development stage
Preclinical
Modality
Small Molecules
01

Overview

6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL is a boron-containing heterocyclic compound, specifically a sulfonylated diazaborine derivative with the molecular formula C₉H₁₃BN₂O₃S₂ and an average molecular mass of 272.146 g/mol. Its structure comprises a thieno-diazaborine core fused with a sulfonylpropane substituent and a methyl group. The compound is characterized by a boronate ester linkage, which confers unique electronic and steric properties critical for its biological activity. It acts as a potent inhibitor of bacterial enoyl-acyl carrier protein (ACP) reductase (ENR), a key enzyme in bacterial fatty acid biosynthesis. This inhibition disrupts the synthesis of bacterial cell membranes, leading to bacterial cell death. Due to this mechanism, it is being explored for potential therapeutic applications as an antibacterial agent, particularly against resistant strains of bacteria.

Other names
1,2-Dihydro-1-hydroxy-6-methyl-2-(propanesulfonyl)-thieno(3,2D)(1,2,3)-diazaborine1-hydroxy-6-methyl-2-propylsulfonylthieno[3,2-d]diazaborinineDiazaborine compound 2b18Thieno(3,2-d)(1,2,3)diazaborine, 1,2-dihydro-1-hydroxy-6-methyl-2-(propylsulfonyl)-6-methyl-2-(propane-1-sulfonyl)-1H,2H-thieno[3,2-d][1,2,3]diazaborinin-1-ol
02

Targets

InhA

Beyond the preview

Go deeper on 6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call